ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jul 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
September 2026
Nuclear Technology
August 2026
Fusion Science and Technology
Latest News
Texas A&M welcomes uranium conversion research
The Texas A&M Engineering Experiment Station (TEES) has signed a research agreement with Quantum Leap Energy (QLE) “to advance and de-risk the commercial production of high-purity uranium hexafluoride (UF6).”
QLE is an Austin, Texas–based subsidiary of ASP Isotopes (ASPI), which is developing an isotope enrichment platform for applications in nuclear energy, nuclear medicine, and semiconductors. QLE specializes in the uranium conversion step of the nuclear fuel cycle—the conversion of yellowcake uranium concentrate (U3O8) into UF6 prior to enrichment.
Jakub Nowak, Adam Konefał, Andrzej Orlef, Maria Sokół
Nuclear Science and Engineering | Volume 200 | Number 9 | September 2026 | Pages 2063-2080
Research Article | doi.org/10.1080/00295639.2025.2567810
Articles are hosted by Taylor and Francis Online.
In this work, we applied Monte Carlo simulations (GATE/GEANT4) to examine the dose enhancement effect of gold nanoparticles (GNPs) for the proton energies used in clinical radiotherapy (60, 120, and 180). The gold mass concentrations were from 0.5 to 29.5 mg/cm3for the nanoparticles completely filled with gold atoms and from 0.01 to 0.39 mg/cm3for spherical nanostructures with a single atomic layer. The region within the Bragg peak was considered of interest for therapeutic benefits. The influence of the concentrations and the shapes of the GNPs on a local dose increase in the biological environment represented by the water was studied and a relatively small dose increase was observed. The dose enhancement factor (DEF) was found to increase with the gold concentration, being the highest for the target volume when the nanoparticles were fully filled by gold atoms. The maximum increases in DEF did not exceed tenths of a percent, except for nanospheres and nanocubes, where at the maximum considered concentrations of GNPs (29.5 mg/cm3) they reached about 1.3% for the GEANT4-DNA models and even exceeded 1.5% for the Livermore models. Furthermore, in order to explain the dose increase mechanism we compared the model of a spherical nanoparticle filled with gold atoms with a spherical nanoparticle made of a single atomic layer. This study confirms the potential of Monte Carlo simulations of the radiosensitization/radioenhancement processes in proton therapy that uses GNPs. Further studies of the basic mechanisms responsible for the radiosensitization effect of GNPs in therapeutic proton energy ranges are necessary.